User:Mr. Ibrahem/Stiripentol

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Stiripentol
Clinical data
Pronunciationstir"i pen' tol
Trade namesDiacomit
AHFS/Drugs.comMonograph
MedlinePlusa618069
License data
Pregnancy
category
  • AU: B3
Routes of
administration
By mouth
Drug classAnticonvulsant[1]
Legal status
Legal status
Identifiers
  • (RS)-(E)-4,4-dimethyl-1-[3,4(methylenedioxy)-phenyl]-1-penten-3-ol
Chemical and physical data
FormulaC14H18O3
Molar mass234.295 g·mol−1
3D model (JSmol)
  • O1c2ccc(cc2OC1)/C=C/C(O)C(C)(C)C
  • InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+ checkY
  • Key:IBLNKMRFIPWSOY-FNORWQNLSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Stiripentol, sold under the brand name Diacomit, is a medication used to treat a form of epilepsy known as severe myoclonic epilepsy in infancy (SMEI, Dravet syndrome).[4][1] It is taken by mouth.[1] It is taken with clobazam in children over the age of 2 years.[1]

Common side effects include loss of appetite, weight loss, trouble sleeping, sleepiness, and poor coordination.[4] Other side effects may include low neutrophils, low platelets, and suicide.[1] Use during pregnancy may harm the baby.[1] It is a anticonvulsant with the chemical structure of an aromatic allylic alcohol.[1]

Stiripentol was approved for medical use in Europe in 2007 and the United States in 2018.[4][1] In the United Kingdom 250 mg twice per day for a month costs the NHS about £280 as of 2021.[5] In the United States this amount costs about 1,600 USD.[6]

References[edit]

  1. ^ a b c d e f g h "Stiripentol Monograph for Professionals". Drugs.com. 31 August 2020. Archived from the original on 11 October 2020. Retrieved 8 November 2020.
  2. ^ "Diacomit 250mg hard capsules - Summary of Product Characteristics (SmPC)". (emc). 31 May 2019. Archived from the original on 13 November 2020. Retrieved 8 November 2020.
  3. ^ "Diacomit- stiripentol capsule Diacomit- stiripentol powder, for suspension". DailyMed. 15 May 2020. Archived from the original on 6 August 2020. Retrieved 8 November 2020.
  4. ^ a b c d e f "Diacomit EPAR". European Medicines Agency. Archived from the original on 12 November 2020. Retrieved 8 November 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  5. ^ a b BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 347. ISBN 978-0-85711-369-6.{{cite book}}: CS1 maint: date format (link)
  6. ^ "Diacomit Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 20 April 2021. Retrieved 14 October 2021.